Rapid virological response as a predictor of sustained response in HCV-infected patients with persistently normal alanine aminotransferase levels: A multicenter study

HCV carriers with normal alanine aminotransferase levels: Healthy persons or severely ill patients?

(2009) Claudio Puoti et al.   European Journal of Internal Medicine

Tailoring the length of antiviral treatment for hepatitis C

(2009) A. Mangia et al.   GUT

Shortened treatment duration in treatment-naive genotype 1 HCV patients with rapid virological response: A meta-analysis

(2009) Christophe Moreno et al.   JOURNAL OF HEPATOLOGY

A 2-log drop in viral load at 1 month is the best predictor of sustained response in HCV patients with normal ALT: a kinetic prospective study

(2009) P. Deltenre et al.   JOURNAL OF VIRAL HEPATITIS

Treatment of hepatitis C virus carriers with persistently normal alanine aminotransferase levels with peginterferon α-2a and ribavirin: a multicentric study

(2009) Claudio Puoti et al.   LIVER INTERNATIONAL

Diagnosis, management, and treatment of hepatitis C: An update

(2008) Marc G. Ghany et al.   HEPATOLOGY

Expert opinion on the treatment of patients with chronic hepatitis C

(2008) S. Zeuzem et al.   JOURNAL OF VIRAL HEPATITIS

Antiviral Treatment of HCV Carriers with Persistently Normal ALT Levels

(2008) Claudio Puoti et al.   MINI-REVIEWS IN MEDICINAL CHEMISTRY